The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

Keliang Wang(Guizhou University), Chawnshang Chang(China Medical University)
Nature Communications
June 1, 2020
Cited by 92


Related Papers